Searchable abstracts of presentations at key conferences in endocrinology

ea0020p63 | Thyroid | ECE2009

Analysis of the genetic markers: ANLN, BIRC5, UBE2C, IRAK1, ZMYCD11, CENPA in needle aspiration cytology (FNA) of thyroid and their used as targets for molecular-diagnosis and prognostic value

Mato Eugenia , Martin-Campos Jesus , Mora Josefina , Lerma Enrique , Bell Olga , de Leiva Alberto

Thyroid carcinoma is the most common endocrine malignancy. However, the absence of prognostic markers for identified well-differentiated tumors versus undifferentiated/anaplastic or poorly differentiated enhances of the progression of recurrent forms with an unfavorable prognosis. In order to identify potential markers for thyroid cancer prognosis prediction, we analyzed by cDNA micro-array the gene expression profile of tumors of the thyroid, with different degrees of maligna...

ea0081ep106 | Adrenal and Cardiovascular Endocrinology | ECE2022

11-deoxycorticosterone producing adrenal hyperplasia as a very unusual cause of endocrine hypertension: case report and systematic review of the literature

Roca Queralt Asla , Simo Helena Sarda , Puertas Enrique Lerma , Hanzu Felicia Alexandra , Urgell Rull Eulalia , Perez Garcia Jose Ignacio , Youdale Susan Webb , Maso Ana Aulinas

11-deoxycorticosterone (DOC) is an aldosterone precursor synthesized from progesterone and converted to corticosterone in the adrenal cortex. DOC overproduction due to an adrenal lesion is a very rare cause of mineralocorticoid-induced hypertension. The objective of this study is to provide the most relevant clinical features that clinicians dealing with patients presenting with the hallmarks of hypertension due to DOC-producing adrenal lesions should be aware of. We report a ...